APPB (Applied Biosciences) EBITDA Margin %: -749.41% (As of Dec. 2019)

What is Applied Biosciences EBITDA Margin %?

Applied Biosciences APPB 12 EBITDA Margin % is -749.41% as of Dec. 2019. GuruFocus rates APPB with a GF Score™ of 12/100.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Applied Biosciences's EBITDA for the three months ended in Dec. 2019 was $-1.27 Mil. Applied Biosciences's Revenue for the three months ended in Dec. 2019 was $0.17 Mil. Therefore, Applied Biosciences's EBITDA margin for the quarter that ended in Dec. 2019 was -749.41%.

Applied Biosciences (OTCPK:APPB) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Applied Biosciences EBITDA Margin % Related Terms

Applied Biosciences EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Applied Biosciences's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Applied Biosciences EBITDA Margin % Chart

Applied Biosciences Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

EBITDA Margin %

0.00

-260.87

-1,091.92

Applied Biosciences Quarterly Data
	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19
EBITDA Margin %	Get a 7-Day Free Trial															-335.35	-67.23	-209.48	-318.44	-749.41

APPB vs CNABQ, OWCP, CXUS: EBITDA Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Applied Biosciences's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Applied Biosciences EBITDA Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Applied Biosciences's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Applied Biosciences's EBITDA Margin % falls into.

Save Embed

12GF Score

Applied Biosciences Corp APPB

EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Applied Biosciences EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Applied Biosciences's EBITDA Margin % for the fiscal year that ended in Mar. 2018 is calculated as

EBITDA Margin %	=	EBITDA (A: Mar. 2018 )	/	Revenue (A: Mar. 2018 )
	=	-2.162	/	0.198
	=	-1,091.92 %

Applied Biosciences's EBITDA Margin % for the quarter that ended in Dec. 2019 is calculated as

EBITDA Margin %	=	EBITDA (Q: Dec. 2019 )	/	Revenue (Q: Dec. 2019 )
	=	-1.274	/	0.17
	=	-749.41 %

Frequently Asked Questions Learn more about EBITDA Margin % →

What does a EBITDA Margin % of -749.41% mean?

Applied Biosciences (APPB) has a EBITDA Margin % of -749.41% as of Dec. 2019. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Applied Biosciences and its competitors.

Is Applied Biosciences' EBITDA Margin % too high?

Applied Biosciences' current EBITDA Margin % is -749.41%. Overall, Applied Biosciences has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.

How does Applied Biosciences' EBITDA Margin % compare to CNABQ and OWCP?

Applied Biosciences' EBITDA Margin % of -749.41% can be compared against companies in the Drug Manufacturers industry. The industry median EBITDA Margin % is 12.44. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good EBITDA Margin % for a Drug Manufacturers company?

The median EBITDA Margin % among Drug Manufacturers companies is 12.44, based on 955 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high EBITDA Margin % mean?

A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Applied Biosciences and its competitors. For the Drug Manufacturers industry, the median EBITDA Margin % is 12.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Applied Biosciences's current EBITDA Margin % is -749.41%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Applied Biosciences stock overvalued right now?

Applied Biosciences (APPB) has a current EBITDA Margin % of -749.41%. The current EBITDA Margin % is -749.41%. Applied Biosciences' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is EBITDA Margin % calculated?

EBITDA Margin % is calculated from a company's financial statements. For Applied Biosciences (APPB), the current EBITDA Margin % is -749.41% as of Dec. 2019. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Applied Biosciences Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies CNABQ OWCP CXUS CANB GSRX LITH GENH PCYN EVIO ACCA ZTS TSE:4502 XTER:MRK HKSE:03692 TSE:4523 SZSE:000661 TSE:4507 SZSE:000538 NSE:SUNPHARMA SZSE:300601

Address 112 North Curry Street, 18th Floor, Carson, NY, USA, 89703

Website https://www.appliedbiocorp.com

Applied Biosciences Corp is a vertically integrated company focused on the development and commercialization of novel, science-driven, synthetic cannabinoid therapeutics / biopharmaceuticals that target the endocannabinoid system to treat a wide-range of diseases across multiple therapeutic areas. The company also deliver high-quality consumer and OTC THC-free CBD products that promote overall health and wellbeing as well as state-of-the-art testing and analytics capabilities to its customers.

12GF Score

Get the complete analysis for APPB

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00

Price

View APPB Analysis

See EBITDA Margin % data for all stocks →